FOXO4 May Be a Biomarker of Postmenopausal Osteoporosis

References

• National Institutes of Health. Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consensus Development Panel on Osteoporosis. JAMA. 2001;285(6):785–795. doi:10.1001/jama.285.6.785
   PubMedGoogle Scholar
• Lerner UH. Bone remodeling in post-menopausal osteoporosis. J Dent Res. 2006;85(7):584–595. doi:10.1177/154405910608500703
   PubMed Web of Science ®Google Scholar
• Marottoli RA, Berkman LF, Cooney LM Jr. Decline in physical function following hip fracture. J Am Geriatr Soc. 1992;40(9):861–866. doi:10.1111/j.1532-5415.1992.tb01980.x
   PubMed Web of Science ®Google Scholar
• Sotornik I. [Osteoporosis - epidemiology and pathogenesis]. Vnitr Lek. 2016;62(Suppl 6):84–87. Arabic.
   PubMedGoogle Scholar
• Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46–56. doi:10.5152/eurjrheum.2016.048
   PubMed Web of Science ®Google Scholar
• Lewiecki EM, Leader D, Weiss R, Williams SA. Challenges in osteoporosis awareness and management: results from a survey of US postmenopausal women. J Drug Assess. 2019;8(1):25–31. doi:10.1080/21556660.2019.1579728
   PubMed Web of Science ®Google Scholar
• Oden A, McCloskey EV, Kanis JA, Harvey NC, Johansson H. Burden of high fracture probability worldwide: secular increases 2010–2040. Osteoporos Int. 2015;26(9):2243–2248. doi:10.1007/s00198-015-3154-6
   PubMed Web of Science ®Google Scholar
• Baccaro LF, Conde DM, Costa-Paiva L, Pinto-Neto AM. The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil. Clin Interv Aging. 2015;10:583–591. doi:10.2147/CIA.S54614
   PubMed Web of Science ®Google Scholar
• Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010;327(5966):656–661. doi:10.1126/science.1178331
   PubMed Web of Science ®Google Scholar
• Horton MA, Spragg JH, Bodary SC, Helfrich MH. Recognition of cryptic sites in human and mouse laminins by rat osteoclasts is mediated by beta 3 and beta 1 integrins. Bone. 1994;15(6):639–646. doi:10.1016/8756-3282(94)90312-3
   PubMed Web of Science ®Google Scholar
• Parfitt AM. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem. 1994;55(3):273–286. doi:10.1002/jcb.240550303
   PubMed Web of Science ®Google Scholar
• Parfitt AM. Osteoclast precursors as leukocytes: importance of the area code. Bone. 1998;23(6):491–494. doi:10.1016/S8756-3282(98)00140-9
   PubMed Web of Science ®Google Scholar
• Zambonin Zallone A, Teti A, Primavera MV. Monocytes from circulating blood fuse in vitro with purified osteoclasts in primary culture. J Cell Sci. 1984;66:335–342. doi:10.1242/jcs.66.1.335
   PubMed Web of Science ®Google Scholar
• Braun T, Zwerina J. Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Res Ther. 2011;13(4):235. doi:10.1186/ar3380
   PubMed Web of Science ®Google Scholar
• Amarasekara DS, Yun H, Kim S, Lee N, Kim H, Rho J. Regulation of osteoclast differentiation by cytokine networks. Immune Netw. 2018;18(1):e8. doi:10.4110/in.2018.18.e8
   PubMed Web of Science ®Google Scholar
• Zupan J, Jeras M, Marc J. Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts. Biochem Med. 2013;23(1):43–63. doi:10.11613/BM.2013.007
   Web of Science ®Google Scholar
• Beck F, Hartmann ES, Koehler MI, et al. Immobilization of denosumab on titanium affects osteoclastogenesis of human peripheral blood monocytes. Int J Mol Sci. 2019;20(5):1002. doi:10.3390/ijms20051002
   PubMed Web of Science ®Google Scholar
• Zhou Y, Deng HW, Shen H. Circulating monocytes: an appropriate model for bone-related study. Osteoporos Int. 2015;26(11):2561–2572. doi:10.1007/s00198-015-3250-7
   PubMed Web of Science ®Google Scholar
• Yang Y, Yujiao W, Fang W, et al. The roles of miRNA, lncRNA and circRNA in the development of osteoporosis. Biol Res. 2020;53(1):40. doi:10.1186/s40659-020-00309-z
   PubMed Web of Science ®Google Scholar
• Wang Y, Li L, Moore BT, et al. MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. PLoS One. 2012;7(4):e34641. doi:10.1371/journal.pone.0034641
   PubMed Web of Science ®Google Scholar
• Ding H, Meng J, Zhang W, et al. Medical examination powers miR-194-5p as a biomarker for postmenopausal osteoporosis. Sci Rep. 2017;7(1):16726. doi:10.1038/s41598-017-17075-w
   PubMed Web of Science ®Google Scholar
• Yu T, You X, Zhou H, et al. MiR-16-5p regulates postmenopausal osteoporosis by directly targeting VEGFA. Aging. 2020;12(10):9500–9514. doi:10.18632/aging.103223
   PubMedGoogle Scholar
• Zhang H, Ding W, Ji F, Wu D. MicroRNA-410 participates in the pathological process of postmenopausal osteoporosis by downregulating bone morphogenetic protein-2. Exp Ther Med. 2019;18(5):3659–3666. doi:10.3892/etm.2019.7996
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41:D991–D995. doi:10.1093/nar/gks1193
   PubMed Web of Science ®Google Scholar
• Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118–127. doi:10.1093/biostatistics/kxj037
   PubMed Web of Science ®Google Scholar
• Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882–883. doi:10.1093/bioinformatics/bts034
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:1–5. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Song WM, Zhang B, Wang E. Multiscale embedded gene co-expression network analysis. PLoS Comput Biol. 2015;11(11):e1004574. doi:10.1371/journal.pcbi.1004574
   PubMed Web of Science ®Google Scholar
• Engebretsen S, Bohlin J. Statistical predictions with glmnet. Clin Epigenetics. 2019;11(1):123. doi:10.1186/s13148-019-0730-1
   PubMed Web of Science ®Google Scholar
• Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77. doi:10.1186/1471-2105-12-77
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20. doi:10.1016/j.cell.2004.12.035
   PubMed Web of Science ®Google Scholar
• Yang Z, Liu J, Fu J, Li S, Chai Z, Sun Y. Associations between WNT signaling pathway-related gene polymorphisms and risks of osteoporosis development in Chinese postmenopausal women: a case-control study. Climacteric. 2021;10:1–7.
   Google Scholar
• Srivastava RK, Dar HY, Mishra PK. Immunoporosis: immunology of osteoporosis-role of T cells. Front Immunol. 2018;9:657. doi:10.3389/fimmu.2018.00657
   PubMed Web of Science ®Google Scholar
• de Vries TJ, El Bakkali I, Kamradt T, Schett G, Jansen IDC, D’Amelio P. What are the peripheral blood determinants for increased osteoclast formation in the various inflammatory diseases associated with bone loss? Front Immunol. 2019;10:505. doi:10.3389/fimmu.2019.00505
   PubMed Web of Science ®Google Scholar
• Cheng CF, Chien-Fu Lin J, Tsai FJ, et al. Protective effects and network analysis of natural compounds obtained from Radix dipsaci, Eucommiae cortex, and Rhizoma drynariae against RANKL-induced osteoclastogenesis in vitro. J Ethnopharmacol. 2019;244:112074. doi:10.1016/j.jep.2019.112074
   PubMed Web of Science ®Google Scholar
• Liu L, Zhu Q, Wang J, Xi Q, Zhu H, Gu M. Gene expression changes in human mesenchymal stem cells from patients with osteoporosis. Mol Med Rep. 2015;12(1):981–987. doi:10.3892/mmr.2015.3514
   PubMed Web of Science ®Google Scholar
• Madel MB, Ibanez L, Wakkach A, et al. Immune function and diversity of osteoclasts in normal and pathological conditions. Front Immunol. 2019;10:1408. doi:10.3389/fimmu.2019.01408
   PubMed Web of Science ®Google Scholar
• Fagerberg L, Hallstrom BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13(2):397–406. doi:10.1074/mcp.M113.035600
   PubMed Web of Science ®Google Scholar
• Ma X, Su P, Yin C, et al. The roles of FoxO transcription factors in regulation of bone cells function. Int J Mol Sci. 2020;21(3):692. doi:10.3390/ijms21030692
   PubMed Web of Science ®Google Scholar
• Atkins GJ, Haynes DR, Geary SM, Loric M, Crotti TN, Findlay DM. Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation. Bone. 2000;26(6):653–661. doi:10.1016/S8756-3282(00)00280-5
   PubMed Web of Science ®Google Scholar
• Street J, Bao M, deGuzman L, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA. 2002;99(15):9656–9661. doi:10.1073/pnas.152324099
   PubMed Web of Science ®Google Scholar
• Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 2013;153(1):13–19. doi:10.1093/jb/mvs136
   PubMed Web of Science ®Google Scholar
• Herbert SP, Stainier DY. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol. 2011;12(9):551–564. doi:10.1038/nrm3176
   PubMed Web of Science ®Google Scholar
• Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, Mikos AG. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone. 2008;43(5):931–940. doi:10.1016/j.bone.2008.06.019
   PubMed Web of Science ®Google Scholar
• Marie PJ, Kassem M. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets. Eur J Endocrinol. 2011;165(1):1–10. doi:10.1530/EJE-11-0132
   PubMed Web of Science ®Google Scholar
• Toni R, Di Conza G, Barbaro F, et al. Microtopography of immune cells in osteoporosis and bone lesions by endocrine disruptors. Front Immunol. 2020;11:1737. doi:10.3389/fimmu.2020.01737
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245–252. doi:10.1038/32588
   PubMed Web of Science ®Google Scholar
• Morelli AE, Thomson AW. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev. 2003;196:125–146. doi:10.1046/j.1600-065X.2003.00079.x
   PubMed Web of Science ®Google Scholar
• Weitzmann MN. Bone and the Immune System. Toxicol Pathol. 2017;45(7):911–924. doi:10.1177/0192623317735316
   PubMed Web of Science ®Google Scholar
• Lu C, Yang Z, Jiang S, et al. Forkhead box O4 transcription factor in human neoplasms: cannot afford to lose the novel suppressor. J Cell Physiol. 2019;234(6):8647–8658. doi:10.1002/jcp.27853
   PubMed Web of Science ®Google Scholar
• Beretta GL, Corno C, Zaffaroni N, Perego P. Role of FoxO proteins in cellular response to antitumor agents. Cancers. 2019;11(1):90. doi:10.3390/cancers11010090
   PubMed Web of Science ®Google Scholar
• Zhou L, Sun S, Zhang T, et al. ATP-binding cassette g1 regulates osteogenesis via Wnt/beta-catenin and AMPK signaling pathways. Mol Biol Rep. 2020;47(10):7439–7449. doi:10.1007/s11033-020-05800-0
   PubMed Web of Science ®Google Scholar
• Ayo-Yusuf OA, Olutola BG. Epidemiological association between osteoporosis and combined smoking and use of snuff among South African women. Niger J Clin Pract. 2014;17(2):174–177. doi:10.4103/1119-3077.127542
   PubMed Web of Science ®Google Scholar
• Jagielska I, Kazdepka-Zieminska A, Ludwikowski G, Szymanski W. [Smoking amongst women arriving at an outpatient clinic in hospital. Nicotine addiction versus disorders in the menstrual cycle]. Przegl Lek. 2008;65(10):420–423. Polish.
   PubMedGoogle Scholar
• Han J, Wan M, Ma Z, Hu C, Yi H. Prediction of targets of curculigoside A in osteoporosis and rheumatoid arthritis using network pharmacology and experimental verification. Drug Des Devel Ther. 2020;14:5235–5250. doi:10.2147/DDDT.S282112
   PubMed Web of Science ®Google Scholar